Original London , This is a reproduction of the original artefact. Generally these books are created from careful scans of the original. This allows us to preserve the book accurately and present it in the way the author intended. Intended to form a Fourth Volume of the Compendium. Skip to content For fourteen years Leoni explained that such a move would be an worked hard to make his restaurant one of excellent idea. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Skip to main content. Log in via OpenAthens. Log in using your username and password For personal accounts OR managers of institutional accounts. Forgot your log in details? Register a new account? Forgot your user name or password? Ensuring value, access and uptake of innovative medicines and vaccines, now and in the future Medicines bring huge value to NHS patients. Improving the UK's attractiveness for industry, research, development and manufacturing We're helping to build a thriving environment for medicine discovery so the UK can be the best place in the world to research and develop new medicines and vaccines.
Manufacturing and quality Regulatory science Clinical research Research using animals. Building better partnerships between industry and NHS and across the Life Sciences sector We have a long-standing positive relationship with the NHS, and a record of facilitate the same across various parties across the Life Sciences sector.
Industry Reputation. Building a stronger industry reputation in the UK Everywhere, every day someone relies on the results of our work to ensure their health and wellbeing. Providing international leadership and driving global policy The ABPI is working to ensure that the UK has the best relationship with our international partners for patients, public health and the life sciences sector.
Health Data. Health data and new medicines Building trust in health data use Harnessing the opportunities Enhancing the UK health data environment. Latest blogs and events 22 November Blog Antibiotic resistance: A global, silent pandemic that is solvable ABPI President Ben Osborn explains the problem of antibiotic resistance and what we can do about it.
R and D Investment [3]. Gross fixed capital formation.
0コメント